key: cord-0833173-2hhmyieu
authors: Sahin, Orhan; Yildirmak, Taner; Karacalar, Serap; Aydın, Emine; Ciftci, Mehmet Ali; Bagci, Helin; Yildirim, Sukran; Emeklioglu, Cagdas; Balci, Burcu Gulsah; Genc, Simten; Cingillioglu, Basak; Mihmanli, Veli; Khalil, Asma; Kalafat, Erkan
title: Short‐term outcomes of pregnant women with convalescent COVID‐19 and factors associated with false‐negative polymerase chain reaction test: A prospective cohort study
date: 2021-08-26
journal: Int J Clin Pract
DOI: 10.1111/ijcp.14670
sha: 051b9b15aff2e58962f06eeaaa1097d9fea740d2
doc_id: 833173
cord_uid: 2hhmyieu

AIM: To evaluate the clinical factors associated with false‐negative RT‐PCR results and to report the outcome of a cohort of pregnant women with COVID‐19. METHODS: This cohort study was conducted in a tertiary referral pandemic hospital and included 56 pregnant women. A study including pregnant women with either a laboratory or clinical diagnosis for COVID‐19 were included in the study. The primary outcome was clinical factors associated with false‐negative RT‐PCR results defined as a positive immunoglobulin M assessed by rapid testing in clinically diagnosed patients. Clinical outcomes of laboratory diagnosed patients were also reported. RESULTS: In total, 56 women with either RT‐PCR or clinical COVID‐19 diagnosis were included in the study. Forty‐three women either had RT‐PCR positivity or IgM positivity. The clinical outcome of these pregnancies was as follows: mean maternal age 27.7, immunoglobulin M positive patients 76.7%, RT‐PCR positive patients 55.8%, maternal comorbidities 11.5%, complications in patients below 20 weeks 34.8%, complications in patients above 20 weeks 65.1%, elevated CRP 83.7%, lymphopenia 30.2%, time from hospital admission to final follow‐up days 37 and stillbirth 8.3%. The proportion of women who tested positive for SARS‐CoV‐2 immunoglobulin M was 100% in the RT‐PCR positive group and 56.5% in the clinical diagnosis group (P = .002). The symptom onset to RT‐PCR testing interval longer than a week (risk ratio: 2.72, 95% CI: 1.14‐5.40, P = .003) and presence of dyspnoea (risk ratio: 0.38, 95% CI: 0.14‐0.89, P = .035) were associated with false‐negative RT‐PCR tests. The area under the curve of these parameters predicting false‐negative RT‐PCR was 0.73 (95% CI: 0.57‐0.89). CONCLUSIONS: Symptomatic women with a negative RT‐PCR should not be dismissed as potential COVID‐19 patients, especially in the presence of prolonged symptom onset‐test interval and in women without dyspnoea.

The coronavirus-19 infection (COVID-19) pandemic is reaching its peak with more than 80 million people infected worldwide.

However, the number of pregnant women reported in the literature is disproportionally low. 1 Pregnant women are less likely to be admitted to the hospital compared with non-pregnant adults of similar age. 2 Whether this is because of higher rates of asymptomatic infection in pregnant women or a better ability of pregnant women to isolate themselves that is fencing effect is not clear. Although pregnant women do not appear to be at increased risk of COVID-19 related complications, the rate of iatrogenic preterm birth and caesarean section is increased. 1 Furthermore, vertical transmission of SARS-CoV-2 is yet to be established. However, the accumulating evidence suggests probable vertical transmission in a small percentage of patients. 1 There is still a need for data on pregnant women from different healthcare systems to elucidate clinical and social factors associated with short, as well as long-term, adverse outcomes. Most reports on pregnant women only include reverse transcriptase-polymerase chain reaction (RT-PCR) test positive patients. 3 Patients with a clinical diagnosis are often overlooked and rarely reported. The sensitivity of RT-PCR tests is affected by the sampling technique, storing, and transport of samples. However, clinical factors associated with false-negative RT-PCR testing in pregnant women are unknown. In this study, we aimed to investigate the clinical factors associated with false-negative RT-PCR results and to report the outcome of a cohort of pregnant women with COVID-19. Nasal oxygen support was started in patients with oxygen saturation below 96%. Women with persistently low oxygen saturation below 93%, prolonged tachypnea (respiratory rate >30 per minute), partial oxygen pressure less than 60 mm Hg, or partial oxygen pressure/inspired oxygen ratio less than 300 were admitted to the intensive care unit. Women completing their respective treatment regimens and remaining symptom-free for more than 48 hours were discharged. All patients were called for a follow-examination at least one week following the hospital admission. Presenting patients were offered rapid antibody tests for COVID-19 (Weimi Diagnostic, Guangzhou Weimi Bio-Tech). Patients were assessed for the presence of symptoms, foetal heart rate, and any pregnancy complications. The primary outcome was clinical factors associated with false-negative PCR results defined as a positive immunoglobulin M assessed by rapid testing in clinically diagnosed patients. Secondary outcomes were short term pregnancy outcomes of convalescent pregnant women with COVID-19. 

In total, 56 women with either RT-PCR or clinical COVID-19 diagnosis were included in the study (shown in Figure 1 ). The baseline characteristics of RT-PCR positive and clinical diagnosis groups are presented in Table 1 . There were no significant differences between RT-PCR positive and clinical diagnosis groups regarding maternal age (P = .771), body-mass index (P = .116), smoking status (P = .617), parity (P = .100), presenting symptoms (P > .05 for all), gestational age at presentation (P = .999) and body temperature (P = .841). The As the SARS-CoV2 antibody test gold reference, RT-PCR's apparent sensitivity, specificity, positive likelihood ratio and negative likelihood ratio are 45.71% (95% CI: 28.8%-63.3%), 50.0% (95% CI: 27.2%-72.8%), 0.91% (95% CI: 0.52%-1.61%) and 1.09% (95% CI: 0.64%-1.85%), respectively. (Table 2 ). In the univariable log-binomial regression, symptom onset to RT-PCR testing interval longer than a week (risk ratio: 2.72, 95% CI:

1.14-5.40, P = .003) and presence of dyspnoea (risk ratio: 0.38, 95% CI: 0.14-0.89, P = .035) were associated with false-negative RT-PCR tests ( Table 3 ). The area under the curve of a model incorporating time interval from symptom onset to testing longer than one week (odds ratio: 9.02, 95% CI: 1.04-203.2) and lack of dyspnoea (odds ratio: 4.43, 95% CI: 1.05-21.5) was 0.73 (95% CI: 0.57-0.89) (shown in Figure 2 ). Symptom onset to testing interval and presence of dyspnoea were moderately predictive of falsenegative RT-PCR results.

The treatment details and clinical outcomes of 43 women with laboratory confirmation (RT-PCR or immunoglobulin testing) of COVID-19 are presented in Table 4 . The most common laboratory abnormalities were elevated C-reactive protein (83.7%) and lymphopenia (30.2%). Three women had early pregnancy complications which included one early pregnancy loss, one threatened miscarriage and one pregnancy termination on maternal request. Three women developed severe preeclampsia. One woman with twin pregnancy was delivered at 25 weeks' gestation because of critical COVID-19 and foetal distress. One of the babies was stillborn and the other died two days later in the neonatal intensive care unit.

There were four preterm deliveries and only one of them was spontaneous preterm delivery. 

The strengths of our study include follow-up of these pregnant women and serology testing of clinically diagnosed patients.

However, some limitations apply to our findings. First, we could not validate the rapid immunoglobulin test kits used in this study. In our study, we found all RT-PCR positive patients tested positive for immunoglobulin M, which suggests the sensitivity of this kit is acceptable. Furthermore, the reported specificity of point of care tests was very high. 5 Second, some patients were lost to followup. Eleven (19.6%) of the patients did not return when the antibody test was called. Reasons for not being followed were determined as 

False-negative RT-PCR test is a common problem for COVID-19 diagnosis. Although there are known technical factors associated with false-negative RT-PCR, the clinical factors associated with it in pregnant women are yet to be determined. [7] [8] [9] [10] The false-negative rate in adults is reported to be around 5% but these studies use repeat RT-PCR testing rather than checking seroconvalescence. 11 In nonpregnant adults, SARS-CoV-2 viral loads dramatically decrease a

week from symptom onset. 12 

Short-term pregnancy outcomes were in line with the published literature suggesting a mild course of the disease and few pregnancy complications. A recent publication suggested an increased rate of preeclampsia in women with COVID-19. We had three patients with severe preeclampsia out of 30 women beyond 20 weeks' gestation (10%), a rate which is higher than the incidence of severe preeclampsia (<1%). 14 However, neither our study design nor the sample size is adequate to detect a potentially increased rate of preeclampsia 

Women without dyspnoea and RT-PCR tests performed one week after the onset of symptoms is more likely to have false-negative results. Clinicians should be aware of this factor to avoid patients with severe suspicious symptoms, negative RT-PCR results, and those who do not wish to have a lung tomography scan. Studies involving more patients are needed to clarify the subject.

Subjects have given their written informed consent, and the study protocol as a number (177-19.05.2020) was approved by the local departmental ethics committee of Prof Dr Cemil Tascioglu City

Hospital.

The authors declare no conflict of interest.

Raw data of the study are available upon request to the corresponding author.

Orhan Sahin https://orcid.org/0000-0002-7216-3816

SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes

Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York

UK obstetric surveillance system SARS-CoV-2 infection in pregnancy collaborative group. characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national populationbased cohort study

Point-of-care diagnostic tests for detecting SARS-CoV-2 antibodies: a systematic review and meta-analysis of real-world data

Covid-19 early warning score: A multiparameter screening tool to identify highly suspected patients

False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence

Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads

Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study

Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

Occurrence and timing of subsequent SARS-CoV-2 RT-PCR positivity among initially negative patients. medRxiv

Viral load of SARS-CoV-2 in clinical samples

Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19

Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease

A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: a prospective cohort study

The clinical findings and outcomes of symptomatic pregnant women diagnosed with or suspected of having coronavirus disease 2019 in a tertiary pandemic hospital in Istanbul, Turkey

COVID-19 (SARS-CoV-2) infection in pregnancy: a systematic review

Short-term outcomes of pregnant women with convalescent COVID-19 and factors associated with false-negative polymerase chain reaction test: A prospective cohort study